CSF3R and chronic neutrophilic leukemia: Acquired activating CSF3R mutations have been identified in around 90% of CNL patients and represent the most predominant genetic lesion for this cancer type [87,88], such that these mutations serve as a diagnostic criteria for the disease [85].